No Detail Found!

Effect of pamidronate on pain control in breast cancer patients

Author(s)
TariqParvez Department of Oncology, Surgical Special Unit1, Medical Special Unit2, Services Hospital, Lahore, Pakistan
Abdul MalikSheik Department of Oncology, Surgical Special Unit1, Medical Special Unit2, Services Hospital, Lahore, Pakistan
Ashfaq Ahmed Department of Oncology, Surgical Special Unit1, Medical Special Unit2, Services Hospital, Lahore, Pakistan
Abstract
Objective: One of the common complaints in advanced breast cancer is pain. This is due to osseous metastasis. Analgesics, along with chemotherapy and hormonal therapy, are the mainstay of treatment. Multifocal bone disease that is refractory to above routine treatments can benefit from a series of agents like Pamidronate. Design : Prospective comparative study. Place and Duration of Study: Study was carried out from February 1998 to January 2001 in the Department of Radiotherapy / Oncology, Services Hospital, Lahore. Subjects and Methods: Sixty patients suffering from metastatic breast cancer (mainly to bones) initially treated with chemotherapy or hormonal therapy and analgesics were treated with 60-90 mg of injection Pamidronate by 4-hour intravenous infusion once a month for three or more months. The intensity of pain was assessed by the memorial symptom assessment scale and marked on the pain control performa according to frequency of pain, severity of pain or interference in daily activities due to pain at the start and after six months time of incluson in the study. Difference in frequency of pain, severity or interference in daily routine was measured for each patient individually. Results: Marked pain relief was reported by 60% of patients who were additionally taking Pamidronate as compared to 43.3% patients who were not taking Pamidronate. Reduction in pain and analgesic demand is noted more in chemotherapy group with Pamidronate as compared to hormonal therapy group. Conclusion: Pamidronate can be additionally used in resistant cases for pain control. .
Publication Details
Page(s) 32-35
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 12, Issue: 1, Year: 2002

Request the full text from PASTIC

Keywords
Analgesics, Breast neoplasm, Osteolysis, Drug therapy, Pain Measurement
References
Tubiana-HulinM .1998 .LiechtensteiAn, PorterL. Long-term Pamidronattereatmeontfadvancedmultiplmeyeloma References patientsreducesskeletaelvents:myelomaaredia studygroup. JCiin Oncoi, 16 : 593-602.
Kaye HansenH,S HansenH . .Medical ment. NewYorkO, : .
Foley KM,Samuel H .1993 .Cancerprincipleand pra­c 21. Ciba-GeigyCorporatioAnr.edia(Pamidronatep)ackage ticeofoncologyP.hiladelphia. , : 2807-41.
Holten-VerzantvoATo .2001 .Pall­ia breasctancerw:hatto expectin 2001 and beyond. tivePamidronattereatmeinntpatientwsithbonemeta­s Oncologist, 11 : 491-8.
.1997 .. Geneva.WHO 1996. Cancer, 80(suppl 8) : 1668-73.
Hughes DE,Uy HL .1995 .Bisphosphonates tom prevalencec,haracteristaicnsd distressin a promoteaspoptosiisn maurineosteoclasintvsitro and cancerpopulationQ. JBone MinerBes, 10 : 1478-87.
Shipman CM .1996 .. Apperley JF. Bisphosph­o OncoiCiinNorthAm, 21 : .
.1988 .factorisn bonematrixC. ibaFoundSymp, 136 : 665-72.
0

Citations

0

Downloads

62

Views